PubRank

Yasushi Tomita

Author PubWeight™ 61.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. Am J Hum Genet 2003 1.55
2 Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis. Rheumatology (Oxford) 2010 1.49
3 Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: a randomized double-blind, placebo-controlled study in healthy volunteers. Arch Dermatol Res 2011 1.43
4 Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 2004 1.26
5 Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan. Am J Hum Genet 2004 1.07
6 What is the novel clinical finding in dyschromatosis symmetrica hereditaria? J Dermatol 2012 1.07
7 Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. Mov Disord 2006 1.06
8 Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease. Hum Mol Genet 2013 1.02
9 The unfolded protein response is activated in differentiating epidermal keratinocytes. J Invest Dermatol 2009 1.01
10 Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albino patients. J Invest Dermatol 2003 1.00
11 Mutation analysis of the ADAR1 gene in dyschromatosis symmetrica hereditaria and genetic differentiation from both dyschromatosis universalis hereditaria and acropigmentatio reticularis. J Invest Dermatol 2005 0.98
12 High frequency of Hermansky-Pudlak syndrome type 1 (HPS1) among Japanese albinism patients and functional analysis of HPS1 mutant protein. J Invest Dermatol 2005 0.96
13 Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. J Autoimmun 2004 0.96
14 Dyschromatosis symmetrica hereditaria associated with neurological disorders. J Dermatol 2008 0.96
15 A case of oral geotrichosis caused by Geotrichum capitatum in an old patient. Jpn J Infect Dis 2007 0.95
16 Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes. J Dermatol 2008 0.93
17 Characterization of the human RAB38 and RAB7 genes: exclusion of new major pathological loci for Japanese OCA. J Dermatol Sci 2003 0.91
18 Oculocutaneous albinism type 4: six novel mutations in the membrane-associated transporter protein gene and their phenotypes. Pigment Cell Res 2006 0.90
19 PCR and PCR-RFLP techniques targeting the DNA topoisomerase II gene for rapid clinical diagnosis of the etiologic agent of dermatophytosis. J Dermatol Sci 2004 0.90
20 Apocrine cystadenoma and apocrine hidrocystoma: examination of 21 cases with emphasis on nomenclature according to proliferative features. J Cutan Pathol 2007 0.89
21 Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun 2004 0.89
22 Ultrastructural features of trafficking defects are pronounced in melanocytic nevus in Hermansky-Pudlak syndrome type 1. J Invest Dermatol 2005 0.88
23 Recent advances in genetic analyses of oculocutaneous albinism types 2 and 4. J Dermatol Sci 2008 0.88
24 Evaluation of cetirizine hydrochloride-based therapeutic strategy for chronic urticaria. Nagoya J Med Sci 2008 0.87
25 Five novel mutations in tyrosinase gene of Japanese and Indian patients with oculocutaneous albinism type I (OCA1). J Invest Dermatol 2005 0.86
26 Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes. Exp Dermatol 2010 0.86
27 Genotype analysis of Candida albicans isolates obtained from different body locations of patients with superficial candidiasis using PCRs targeting 25S rDNA and ALT repeat sequences of the RPS. J Dermatol Sci 2006 0.85
28 IgE and IgG(4) autoantibodies against DFS70/LEDGF in atopic dermatitis. Autoimmunity 2011 0.84
29 High frequency of the Ala481Thr mutation of the P gene in the Japanese population. Am J Med Genet A 2003 0.84
30 Dermoscopic evaluation of vascular structures of various skin tumors in Japanese patients. J Dermatol 2010 0.84
31 CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. Am J Pathol 2009 0.84
32 A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1). J Dermatol Sci 2002 0.84
33 Anti-p80 coilin autoantibodies react with a conserved epitope and are associated with anti-DFS70/LEDGF autoantibodies. J Autoimmun 2005 0.83
34 Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan. J Dermatol 2011 0.83
35 GD3 synthase gene knockout mice exhibit thermal hyperalgesia and mechanical allodynia but decreased response to formalin-induced prolonged noxious stimulation. Pain 2005 0.83
36 Increase of pro-opiomelanocortin mRNA prior to tyrosinase, tyrosinase-related protein 1, dopachrome tautomerase, Pmel-17/gp100, and P-protein mRNA in human skin after ultraviolet B irradiation. J Invest Dermatol 2002 0.83
37 Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, similar to that seen in the psoriatic condition. J Invest Dermatol 2010 0.83
38 LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J Invest Dermatol 2006 0.82
39 Microsatellite-based genotyping of Candida albicans isolated from patients with superficial candidiasis. Med Mycol J 2011 0.82
40 CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis. J Rheumatol 2009 0.82
41 Genotyping of Candida albicans on the basis of polymorphisms of ALT repeats in the repetitive sequence (RPS). J Dermatol Sci 2005 0.81
42 HLA-associated production of anti-DFS70/LEDGF autoantibodies and systemic autoimmune disease. J Autoimmun 2006 0.81
43 Effects of topical vehicles on growth of the lipophilic Malassezia species. J Dermatol Sci 2002 0.81
44 XPA gene mutations resulting in subtle truncation of protein in xeroderma pigmentosum group A patients with mild skin symptoms. J Invest Dermatol 2010 0.81
45 Ten novel mutations of the ADAR1 gene in Japanese patients with dyschromatosis symmetrica hereditaria. J Invest Dermatol 2006 0.81
46 Large ulcerated perianal hidradenoma papilliferum in a young female. Dermatol Surg 2003 0.80
47 Histamine is involved in ultraviolet B-induced pigmentation of guinea pig skin. J Invest Dermatol 2002 0.80
48 Genotyping of Candida albicans by fragment analysis of microsatellites combined with 25S rDNA and RPS-based strategies. Nihon Ishinkin Gakkai Zasshi 2009 0.80
49 Multiple pigmented basal cell carcinomas arising in the normal-appearing skin after radiotherapy for carcinoma of the cervix. Dermatol Surg 2003 0.80
50 Successful treatment of warts with a combination of maxacalcitol ointment and salicylic acid sticking plaster. J Dermatol 2006 0.80
51 Nodular fasciitis of the forehead in a pediatric patient. Dermatol Surg 2003 0.80
52 Four novel ADAR1 gene mutations in patients with dyschromatosis symmetrica hereditaria. J Dermatol 2011 0.79
53 Oculocutaneous albinism type IV: A boy of Moroccan descent with a novel mutation in SLC45A2. Am J Med Genet A 2009 0.79
54 Anti-SS-A/Ro antibody determination by indirect immunofluorescence and comparison of different methods of anti-nuclear antibody screening: evaluation of the utility of HEp-2 cells transfected with the 60 kDa SS-A/Ro as a substrate. Mod Rheumatol 2008 0.79
55 OCA4: evidence for a founder effect for the p.D157N mutation of the MATP gene in Japanese and Korean. Pigment Cell Res 2005 0.78
56 Mutation analyses of patients with dyschromatosis symmetrica hereditaria: five novel mutations of the ADAR1 gene. J Dermatol Sci 2010 0.78
57 Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: clinicopathological analysis of 27 patients. Cancer Sci 2008 0.78
58 Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis. J Hum Genet 2002 0.78
59 Messenger RNA levels of melanogenesis-associated genes in lentigo senilis lesions. J Dermatol Sci 2004 0.78
60 Interval sentinel lymph nodes in patients with cutaneous melanoma: a single-institution study in Japan. J Dermatol 2010 0.78
61 beta2-Adrenoceptor agonists enhance cytokine-induced release of thymic stromal lymphopoietin by lung tissue cells. Int Arch Allergy Immunol 2010 0.78
62 Cyclosporin A induces the unfolded protein response in keratinocytes. Arch Dermatol Res 2011 0.77
63 Four novel mutations of the ADAR1 gene in dyschromatosis symmetrica hereditaria. J Dermatol Sci 2008 0.77
64 [Thrombotic thrombocytopenic purpura with mixed connective tissue disease. A case report]. Arerugi 2009 0.77
65 Successful topical hemotherapy with a new occlusive dressing for an intractable ulcer on the toe. J Dermatol 2009 0.77
66 Investigation on the IVS5 +5G --> a splice site mutation of HPS1 gene found in Japanese patients with Hermansky-Pudlak syndrome. J Dermatol Sci 2004 0.77
67 Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node. J Cutan Pathol 2013 0.77
68 A case of systemic lupus erythematosus: continued association of circulating prolactin levels with disease activity over a 4-year follow-up period. Mod Rheumatol 2005 0.76
69 Detection of Merkel cell polyomavirus in cutaneous squamous cell carcinoma before occurrence of Merkel cell carcinoma. J Am Acad Dermatol 2011 0.76
70 Establishment of tyrosinase sequence database in normally pigmented Indians and Japanese for rapid determination of novel mutations. J Dermatol Sci 2005 0.76
71 The effect of the long-term cultivation on telomere length and morphology of cultured epidermis. J Dermatol Sci 2004 0.75
72 Establishment of a screening system for chemicals that upregulate a melanoma antigen, Melan-A/MART-1. Tohoku J Exp Med 2009 0.75
73 Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma. J Dermatol 2010 0.75
74 Functional analysis of OCA4 mutant sequences using under white mouse melanocytes. Pigment Cell Melanoma Res 2009 0.75
75 Giant superficial basal cell carcinoma of the scrotum. Eur J Dermatol 2005 0.75
76 A case of refractory bullous pemphigoid with plasmapheresis-associated thrombopenia: efficacy of pulsed intravenous cyclophosphamide therapy. J Dermatol 2004 0.75
77 Detection of various types of human papillomavirus DNA, mainly belonging to the cutaneous-group, more frequently in normal tissue than in squamous cell carcinomas of the lip. J Dermatol Sci 2004 0.75
78 A case of a childhood linear scleroderma with limb asymmetry. Mod Rheumatol 2004 0.75
79 Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases. Pathol Int 2012 0.75
80 Dyschromatosis symmetrica hereditaria by ADAR1 mutations and viral encephalitis: a hidden link? Int J Dermatol 2013 0.75
81 Effects of oral propranolol on a juxtapapillary capillary hemangioma: a single-subject pilot study. Ophthalmic Surg Lasers Imaging Retina 2015 0.75
82 Epidemiological study of Candida species in cutaneous candidiasis based on PCR using a primer mix specific for the DNA topoisomerase II gene. J Dermatol Sci 2004 0.75
83 A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes. Jpn J Clin Oncol 2008 0.75
84 Anti-ribosomal-P antibodies in a Sjögren syndrome patient associated with lupus erythematosus. J Dermatol 2004 0.75
85 Effects of antiarrhythmic agents on left ventricular function during exercise in patients with chronic left ventricular dysfunction. Ann Nucl Med 2004 0.75
86 Combination of short-pulsed CO2 laser resurfacing and cultured epidermal sheet autografting in the treatment of vitiligo: a preliminary report. Ann Plast Surg 2004 0.75
87 Two novel mutations detected in Japanese patients with oculocutaneous albinism. J Dermatol Sci 2006 0.75
88 The successful use of topical tacrolimus treatment for a chronic actinic dermatitis patient with complications of idiopathic leukopenia. J Dermatol 2003 0.75
89 Dominant dystrophic epidermolysis bullosa caused by a novel G2037R mutation and by a known G2028R mutation in the type VII collagen gene (COL7A1). J Dermatol 2006 0.75
90 Monte Carlo simulation for speckle reduction by a moving diffuser on the natural test image. Appl Opt 2015 0.75
91 A patient with subclinical oculocutaneous albinism type 2 diagnosed on getting severely sunburned. Dermatology 2005 0.75